Study of Chemoimmunotherapy for High-Risk Neuroblastoma
Clinical trial NCT03189706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03189706
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-12
- Primary completion
- 2027-06-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.